Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward A Stadtmauer

Showing results (21-30 of 192) with videos related to

Pageof 20
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2014
Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemiaDaniel J Landsburg, Dan T Vogl, John P Plastaras, et al.
Cancer|February 20, 2020
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapySteven M Bair, Joshua D Brandstadter, Emily C Ayers, et al.
Oncology and Therapy|May 21, 2023
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth InterviewsTodd J Bixby, Christine J Brittle, Patricia A Mangan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 5, 2019
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation PatientsHeather Lazarow, Michele Nicolo, Charlene Compher, et al.
Haematologica|May 29, 2025
Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based studyXinhe Shan, Rowan Kuiper, Chuling Ding, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 18, 2010
Pupil-involving third nerve palsy as a manifestation of anti-myelin-associated glycoprotein neuropathyMadhura A Tamhankar, Steven L Galetta, Mina Massaro, et al.
Journal of Clinical Apheresis|September 7, 2010
Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costsYvette C Tanhehco, Jill Adamski, Mary Sell, et al.
Hematology/Oncology Clinics of North America|December 29, 2023
Chimeric Antigen Receptor T Cells in the Treatment of Multiple MyelomaZainul S Hasanali, Beatrice Razzo, Sandra P Susanibar-Adaniya, et al.
American Journal of Hematology|July 11, 2008
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosisRebecca L Olin, Kim E Nichols, Mojdeh Naghashpour, et al.
British Journal of Haematology|February 13, 2024
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trialRuta Brazauskas, Kathryn Flynn, Amrita Krishnan, et al.
Pageof 20

Showing results (21-30 of 192) with videos related to

Sort By:
Pageof 20
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2014
Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemiaDaniel J Landsburg, Dan T Vogl, John P Plastaras, et al.
Cancer|February 20, 2020
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapySteven M Bair, Joshua D Brandstadter, Emily C Ayers, et al.
Oncology and Therapy|May 21, 2023
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth InterviewsTodd J Bixby, Christine J Brittle, Patricia A Mangan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 5, 2019
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation PatientsHeather Lazarow, Michele Nicolo, Charlene Compher, et al.
Haematologica|May 29, 2025
Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based studyXinhe Shan, Rowan Kuiper, Chuling Ding, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 18, 2010
Pupil-involving third nerve palsy as a manifestation of anti-myelin-associated glycoprotein neuropathyMadhura A Tamhankar, Steven L Galetta, Mina Massaro, et al.
Journal of Clinical Apheresis|September 7, 2010
Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costsYvette C Tanhehco, Jill Adamski, Mary Sell, et al.
Hematology/Oncology Clinics of North America|December 29, 2023
Chimeric Antigen Receptor T Cells in the Treatment of Multiple MyelomaZainul S Hasanali, Beatrice Razzo, Sandra P Susanibar-Adaniya, et al.
American Journal of Hematology|July 11, 2008
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosisRebecca L Olin, Kim E Nichols, Mojdeh Naghashpour, et al.
British Journal of Haematology|February 13, 2024
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trialRuta Brazauskas, Kathryn Flynn, Amrita Krishnan, et al.
Pageof 20